Drug developer EpiVario locks in $445K seed
Philadelphia-based EpiVario, an early-stage drug discovery and developer, has raised $445,000 in seed funding. The investors were not named.
11 December 2018•1 min read
Philadelphia-based EpiVario, an early-stage drug discovery and developer, has raised $445,000 in seed funding. The investors were not named.
